BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12101522)

  • 1. [Catalytic DNA--deoxyribozymes].
    Nawrot B
    Postepy Biochem; 2002; 48(1):20-33. PubMed ID: 12101522
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of cleavage sites in the HIV-1 TAR RNA by 10-23 and 8-17 catalytic motif containing DNA enzymes.
    Chakraborti S; Banerjea AC
    Biomacromolecules; 2003; 4(3):568-71. PubMed ID: 12741771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An efficient RNA-cleaving DNA enzyme that synchronizes catalysis with fluorescence signaling.
    Mei SH; Liu Z; Brennan JD; Li Y
    J Am Chem Soc; 2003 Jan; 125(2):412-20. PubMed ID: 12517153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro cleavage of hepatitis B virus C mRNA by 10-23 DNA enzyme.
    Hou W; Wo JE; Li MW; Liu KZ
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):573-6. PubMed ID: 16286265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion analysis in the catalytic region of the 10-23 DNA enzyme.
    Zaborowska Z; Schubert S; Kurreck J; Erdmann VA
    FEBS Lett; 2005 Jan; 579(2):554-8. PubMed ID: 15642375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target site selection for an RNA-cleaving catalytic DNA.
    Cairns MJ; Hopkins TM; Witherington C; Wang L; Sun LQ
    Nat Biotechnol; 1999 May; 17(5):480-6. PubMed ID: 10331809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dinucleotide junction cleavage versatility of 8-17 deoxyribozyme.
    Cruz RP; Withers JB; Li Y
    Chem Biol; 2004 Jan; 11(1):57-67. PubMed ID: 15112995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologically inspired synthetic enzymes made from DNA.
    Schlosser K; Li Y
    Chem Biol; 2009 Mar; 16(3):311-22. PubMed ID: 19318212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of the functional phosphate groups in the catalytic core of deoxyribozyme 10-23.
    Nawrot B; Widera K; Wojcik M; Rebowska B; Nowak G; Stec WJ
    FEBS J; 2007 Feb; 274(4):1062-72. PubMed ID: 17250742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an RNA-cleaving deoxyribozyme with optimal activity at pH 5.
    Kandadai SA; Mok WW; Ali MM; Li Y
    Biochemistry; 2009 Aug; 48(31):7383-91. PubMed ID: 19583262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracing sequence diversity change of RNA-cleaving deoxyribozymes under increasing selection pressure during in vitro selection.
    Schlosser K; Li Y
    Biochemistry; 2004 Aug; 43(30):9695-707. PubMed ID: 15274624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evolution of an RNA-cleaving DNA enzyme into an RNA ligase switches the selectivity from 3'-5' to 2'-5'.
    Flynn-Charlebois A; Prior TK; Hoadley KA; Silverman SK
    J Am Chem Soc; 2003 May; 125(18):5346-50. PubMed ID: 12720447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic DNA (deoxyribozymes) for synthetic applications-current abilities and future prospects.
    Silverman SK
    Chem Commun (Camb); 2008 Aug; (30):3467-85. PubMed ID: 18654692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of deoxyribozymes that synthesize branched RNA.
    Wang Y; Silverman SK
    Biochemistry; 2003 Dec; 42(51):15252-63. PubMed ID: 14690435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic and thermodynamic characterization of the RNA-cleaving 8-17 deoxyribozyme.
    Bonaccio M; Credali A; Peracchi A
    Nucleic Acids Res; 2004; 32(3):916-25. PubMed ID: 14963261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational modification of a selection strategy leads to deoxyribozymes that create native 3'-5' RNA linkages.
    Coppins RL; Silverman SK
    J Am Chem Soc; 2004 Dec; 126(50):16426-32. PubMed ID: 15600344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing the secondary structure and identifying functionally essential nucleotides of pH6DZ1, a fluorescence-signaling and RNA-cleaving deoxyribozyme.
    Shen Y; Brennan JD; Li Y
    Biochemistry; 2005 Sep; 44(36):12066-76. PubMed ID: 16142904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV gene therapy using RNA virus systems.
    Hayafune M; Miyano-Kurosaki N; Kusunoki A; Mouri Y; Takaku H
    Nucleic Acids Symp Ser (Oxf); 2006; (50):79-80. PubMed ID: 17150826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of arm length asymmetry and base substitution on the activity of the 10-23 DNA enzyme.
    Cairns MJ; Hopkins TM; Witherington C; Sun LQ
    Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):323-32. PubMed ID: 11079572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly active low magnesium hammerhead ribozyme.
    Fedoruk-Wyszomirska A; SzymaƄski M; Wyszko E; Barciszewska MZ; Barciszewski J
    J Biochem; 2009 Apr; 145(4):451-9. PubMed ID: 19124457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.